Bioxytran, Inc (BIXT) stock
BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026Market cap $2.56MP/E –Yield –
Bioxytran gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Bioxytran's gross profit for the twelve months ending Jun 30, 2018 was $83.76K, down 25.6% year over year. For fiscal 2017 it was $87.10K, down 42.0% from the year before. The highest annual figure on record is $219.95K in fiscal 2013.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $87.10K | -42.0% |
| FY2016 | Dec 31, 2016 | $150.19K | +25.0% |
| FY2015 | Dec 31, 2015 | $120.14K | +9.6% |
| FY2014 | Dec 31, 2014 | $109.64K | -50.2% |
| FY2013 | Dec 31, 2013 | $219.95K | +15.2% |
| FY2012 | Dec 31, 2012 | $190.98K | +233.8% |
| FY2011 | Dec 31, 2011 | $57.22K | +373.0% |
| FY2010 | Dec 31, 2010 | $12.10K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2018 | Jun 30, 2018 | $12.20K | -39.3% |
| Q1 FY2018 | Mar 31, 2018 | -$1.93K | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.60K | -118.5% |
| Q3 FY2017 | Sep 30, 2017 | $80.09K | +27.2% |
| Q2 FY2017 | Jun 30, 2017 | $20.08K | – |
| Q1 FY2017 | Mar 31, 2017 | -$6.24K | – |
| Q4 FY2016 | Dec 31, 2016 | $35.73K | – |
| Q3 FY2016 | Sep 30, 2016 | $62.94K | – |
See a number that looks wrong?